April 18th 2024
A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference assesses the link between antibiotic use and C difficile infection in Tennessee.
How Did COVID-19 Affect Clostridioides Difficile Testing and Incidence Rates?
June 1st 2021During the COVID-19 surge last year, the federal government stopped the required reporting on healthcare-associated infections (HAI) thus leaving an absence of data and important information on HAI. One study examined the effect the initial pandemic surge had on Clostridioides Difficile infection (CDI) in one hospital.
Watch
Hospital-Associated SAB, CDI More Than Twice as Likely Among Cancer Patients
May 2nd 2021Cancer patients are more than twice as likely to acquire hospital-associated Staphylococcus aureus bacteraemia (HA-SAB) and Clostridioides difficile infection (HA-CDI) than others, a new study from Australia found.
Read More
Improved Testing and Treatment Strategies for C. Difficile Offered in New Review
April 3rd 2021Clostridium difficile infection (CDI) is a leading cause of healthcare-associated infections and the clinical spectrum ranges from asymptomatic colonization to toxic megacolon and fulminant colitis.
Read More
Visitor Contact Precautions Had Little Effect on C Diff Infections in Simulation Study
April 2nd 2021Infection control efforts to combat hospital-onset Clostridioides difficile infection may be better spent on health care workers’ hand hygiene compliance and environmental cleaning than on visitor contact precautions, a new study suggests.
Read More
Rates of Serious Complications Rise with Each Recurrent C diff Infection
March 14th 2021Rates of serious clinical complications of Clostridioides difficile infection rose as the number of recurrent infections increased, underscoring the importance of advancing new treatments to prevent recurrence of the disease, a recent study in SAGE Open Medicine found.
Read More